CN116731951A - Serum-free cell culture medium and application thereof - Google Patents
Serum-free cell culture medium and application thereof Download PDFInfo
- Publication number
- CN116731951A CN116731951A CN202310424864.5A CN202310424864A CN116731951A CN 116731951 A CN116731951 A CN 116731951A CN 202310424864 A CN202310424864 A CN 202310424864A CN 116731951 A CN116731951 A CN 116731951A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- components
- serum
- culture medium
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006143 cell culture medium Substances 0.000 title claims abstract description 20
- 229940088594 vitamin Drugs 0.000 claims abstract description 48
- 229930003231 vitamin Natural products 0.000 claims abstract description 48
- 235000013343 vitamin Nutrition 0.000 claims abstract description 48
- 239000011782 vitamin Substances 0.000 claims abstract description 48
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 48
- 239000001963 growth medium Substances 0.000 claims abstract description 30
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 26
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 24
- 229930003944 flavone Natural products 0.000 claims abstract description 24
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 24
- 235000011949 flavones Nutrition 0.000 claims abstract description 24
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 18
- 239000011573 trace mineral Substances 0.000 claims abstract description 17
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims abstract description 14
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000893536 Epimedium Species 0.000 claims abstract description 12
- 241000241413 Propolis Species 0.000 claims abstract description 12
- 235000018905 epimedium Nutrition 0.000 claims abstract description 12
- 229940069949 propolis Drugs 0.000 claims abstract description 12
- 239000002609 medium Substances 0.000 claims description 24
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 22
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 22
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 20
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 20
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 20
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 20
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 20
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 20
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 20
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 20
- 229930003270 Vitamin B Natural products 0.000 claims description 18
- 235000019156 vitamin B Nutrition 0.000 claims description 18
- 239000011720 vitamin B Substances 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 17
- 235000001014 amino acid Nutrition 0.000 claims description 17
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 16
- 235000010469 Glycine max Nutrition 0.000 claims description 12
- 244000068988 Glycine max Species 0.000 claims description 12
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 11
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 11
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 11
- 102000004877 Insulin Human genes 0.000 claims description 11
- 108090001061 Insulin Proteins 0.000 claims description 11
- 102000004338 Transferrin Human genes 0.000 claims description 11
- 108090000901 Transferrin Proteins 0.000 claims description 11
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 11
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 11
- 229940116977 epidermal growth factor Drugs 0.000 claims description 11
- 150000007946 flavonol Chemical class 0.000 claims description 11
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 11
- 235000011957 flavonols Nutrition 0.000 claims description 11
- 229960000890 hydrocortisone Drugs 0.000 claims description 11
- 229940125396 insulin Drugs 0.000 claims description 11
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 11
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 11
- 235000008696 isoflavones Nutrition 0.000 claims description 11
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 11
- 229940032091 stigmasterol Drugs 0.000 claims description 11
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 11
- 235000016831 stigmasterol Nutrition 0.000 claims description 11
- 239000012581 transferrin Substances 0.000 claims description 11
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 11
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 10
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 10
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 10
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 10
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 10
- 229930064664 L-arginine Natural products 0.000 claims description 10
- 235000014852 L-arginine Nutrition 0.000 claims description 10
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 10
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 10
- 235000019393 L-cystine Nutrition 0.000 claims description 10
- 239000004158 L-cystine Substances 0.000 claims description 10
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 10
- 229930182844 L-isoleucine Natural products 0.000 claims description 10
- 239000004395 L-leucine Substances 0.000 claims description 10
- 235000019454 L-leucine Nutrition 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- 229930195722 L-methionine Natural products 0.000 claims description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 10
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 claims description 10
- 239000005700 Putrescine Substances 0.000 claims description 10
- 229960002648 alanylglutamine Drugs 0.000 claims description 10
- 229960001230 asparagine Drugs 0.000 claims description 10
- 229960005261 aspartic acid Drugs 0.000 claims description 10
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims description 10
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 10
- 229960003067 cystine Drugs 0.000 claims description 10
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 10
- 229960002989 glutamic acid Drugs 0.000 claims description 10
- 229960000367 inositol Drugs 0.000 claims description 10
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 10
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 claims description 10
- 229960000310 isoleucine Drugs 0.000 claims description 10
- 229960003136 leucine Drugs 0.000 claims description 10
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 10
- 235000020778 linoleic acid Nutrition 0.000 claims description 10
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 10
- 229960004452 methionine Drugs 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 claims description 10
- 108700024047 pangamic acid Proteins 0.000 claims description 10
- 239000001103 potassium chloride Substances 0.000 claims description 10
- 235000011164 potassium chloride Nutrition 0.000 claims description 10
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 239000011781 sodium selenite Substances 0.000 claims description 10
- 235000015921 sodium selenite Nutrition 0.000 claims description 10
- 229960001471 sodium selenite Drugs 0.000 claims description 10
- 229960004441 tyrosine Drugs 0.000 claims description 10
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims description 10
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 9
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 8
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 8
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 7
- 229930003756 Vitamin B7 Natural products 0.000 claims description 7
- 229930003761 Vitamin B9 Natural products 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 7
- 235000011912 vitamin B7 Nutrition 0.000 claims description 7
- 239000011735 vitamin B7 Substances 0.000 claims description 7
- 235000019159 vitamin B9 Nutrition 0.000 claims description 7
- 239000011727 vitamin B9 Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 6
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 6
- 229960002885 histidine Drugs 0.000 claims description 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 6
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 235000019766 L-Lysine Nutrition 0.000 claims description 4
- 235000013878 L-cysteine Nutrition 0.000 claims description 4
- 239000004201 L-cysteine Substances 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003537 Vitamin B3 Natural products 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 229960005190 phenylalanine Drugs 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 229960004799 tryptophan Drugs 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims description 4
- 239000011708 vitamin B3 Substances 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 229960002079 calcium pantothenate Drugs 0.000 claims description 3
- 229940088129 calcium pantothenate 10 mg Drugs 0.000 claims description 3
- 229940054665 calcium pantothenate 5 mg Drugs 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940040370 vitamin a 15 mg Drugs 0.000 claims description 3
- 229940089133 vitamin b6 5 mg Drugs 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 4
- 210000002966 serum Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 4
- 230000010261 cell growth Effects 0.000 abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 24
- 235000014633 carbohydrates Nutrition 0.000 description 12
- 102400001368 Epidermal growth factor Human genes 0.000 description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 5
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000004017 serum-free culture medium Substances 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000011085 pressure filtration Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- FAPWYRCQGJNNSJ-CTWWJBIBSA-L calcium;3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound [Ca+2].OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-CTWWJBIBSA-L 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a serum-free cell culture medium and application thereof, which comprises an amino acid component, a vitamin component, a carbohydrate component, a trace element component, an inorganic salt component and other molecular compound components. The culture medium of the invention contains no serum and clear components, avoids the biosafety risk and batch difference caused by using serum, adopts glucose and D-ribose to combine energy supply, combines the growth promotion regulation of propolis flavone and epimedium flavone, has the effect of improving the cell survival rate and proliferation on the basis of maintaining the normal growth of cells, thereby improving the yield and quality stability of biological products and obtaining greater economic benefit.
Description
Technical Field
The invention belongs to the technical field of biological medicines, and particularly relates to a serum-free cell culture medium and a method for cell culture by adopting the serum-free cell culture medium.
Background
With the rapid development of biotechnology, monoclonal antibodies, cytokines, vaccines and various bioactive proteins and other biological products are increasingly used in diagnosis and therapy, and the demand for such products is greatly increased, so that research on the technology for producing biological products by culturing animal cells in vitro on a large scale is increasingly favored.
The traditional serum culture medium is mainly bovine serum, and human serum, horse serum and the like are also used for culturing certain special cells. However, the use of serum has a plurality of disadvantages, firstly, the serum is a very complex mixture, the clear components, content and action mechanism of the serum are still unclear at present, and in particular, some polypeptide growth factors, hormones, lipids and the like are not fully known, which brings a lot of difficulties to research work; secondly, serum is produced in batches, the difference among batches is very large, the similarity of each batch of serum is extremely difficult to ensure, the standardization and continuity of experiments are limited, the use of serum also makes the standardization of experiments and production difficult, and the separation and purification work in the production of certain transgenic protein biological medicines is difficult to complete due to protein.
The serum-free culture medium is a third type of culture medium after the natural culture medium and the synthetic culture medium, and compared with the traditional culture medium, the serum-free culture medium does not contain animal serum or other animal extraction components, but still can meet the requirement of long-time growth and propagation of cells in vitro, has clear components, and is convenient for subsequent experiments and standardization of production. The main components of the serum-free culture medium in the current market are amino acid, vitamin, carbohydrate, inorganic salt and other auxiliary substances, and most of the serum-free culture medium adopts glucose as an energy source, has uneven effects and high price, and is not convenient to store and use compared with the traditional culture medium. According to the invention, the D-ribose and the glucose are combined for energy supply, so that more continuous and long-term energy supply can be provided for cells during logarithmic growth and rapid proliferation of the cells, and meanwhile, the soybean hormone and the traditional Chinese medicine components are added to promote rapid growth and proliferation of the cells, so that the yield and quality stability of biological products are improved, greater economic benefits are obtained, and the prepared culture medium can be stored at normal temperature and is convenient to transport and store.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a serum-free cell culture medium, which has definite chemical components, can obviously improve the cell culture efficiency or the production duration, and provides convenience for the large-scale production of biological products.
In order to achieve the above purpose, the technical scheme provided by the invention is as follows:
a serum-free cell culture medium comprises amino acid component, vitamin component, carbohydrate component, trace element component, inorganic salt component and other molecular compound component,
the amino acid component comprises the following components:
l-histidine 5-20 mg/L
L-leucine 10-30 mg/L
L-isoleucine 15-35 mg/L
L-phenylalanine 5-15 mg/L
L-lysine 20-50 mg/L
L-cysteine 10-20 mg/L
Glycine 10-50 mg/L
L-asparagine 10-50 mg/L
L-glutamic acid 1-10 mg/L
L-alanyl-L-glutamine 1-10 mg/L
L-tryptophan 5-20 mg/L
L-arginine 10-100 mg/L
L-tyrosine 5-20 mg/L
L-aspartic acid 10-30 mg/L
L-cystine 10-30 mg/L
L-methionine 3-10 mg/L
The vitamin component comprises the following components:
vitamin A1-15 mg/L
Vitamin B1 0.5-5 mg/L
Vitamin B2 0.1-1 mg/L
Vitamin B3 0.1-1 mg/L
Vitamin B6 0.5-5 mg/L
Vitamin B7 0.05-2 mg/L
Vitamin B9 2-20 mg/L
Vitamin B15 0.3-5 mg/L
Vitamin C0.5-5 mg/L
Vitamin E1.8-9.4 mg/L
Inositol 5-35 mg/L
1-10 mg/L calcium pantothenate
The carbohydrate component comprises the following ingredients:
glucose 1500-3500 mg/L
D-ribose 1000-3000 mg/L
Putrescine 0.05-5 mg/L
10-20 mg/L of ethanolamine
Linoleic acid 0.05-0.5 mg/L
The trace element component comprises the following components:
copper sulfate pentahydrate 0.05-0.5 mg/L
0.5-5 mg/L zinc sulfate heptahydrate
Ferrous sulfate heptahydrate 0.5-10 mg/L
Cobalt chloride 0.01-0.1 mg/L
Sodium selenite 0.01-1 mg/L
The inorganic salt component comprises the following components:
sodium bicarbonate 1000-3000 mg/L
Magnesium chloride 20-200 mg/L
500-2000 mg/L sodium chloride
100-250 mg/L potassium chloride
The other molecular compound components include the following:
stigmasterol 20-50 mg/L
Flavonol 20-50 mg/L
10-20 mg/L of soybean isoflavone
Insulin 0.1-10 mg/L
Cortisol 0.1-20 mg/L
Epidermal growth factor 0.1-10 mg/L
EDTA disodium 0.1-10 mg/L
Transferrin 10-20 mg/L
Propolis flavone 1-10 mg/L
Epimedium flavone 1-10 mg/L
Preferably, the serum-free cell culture medium comprises:
the amino acid composition is: l-histidine 5mg/L, L-leucine 10mg/L, L-isoleucine 15mg/L, L-phenylalanine 5mg/L, L-lysine 20mg/L, L-cysteine 10mg/L, glycine 10mg/L, L-asparagine 10mg/L, L-glutamic acid 1mg/L, L-alanyl-L-glutamine 1mg/L, L-tryptophan 5mg/L, L-arginine 10mg/L, L-tyrosine 5mg/L, L-aspartic acid 10mg/L, L-cystine 10mg/L, L-methionine 3mg/L.
The vitamin components are as follows: 1mg/L of vitamin A, 0.5mg/L of vitamin B, 0.1mg/L of vitamin B, 0.5mg/L of vitamin B, 0.05mg/L of vitamin B, 9 2mg/L of vitamin B, 0.3mg/L of vitamin B, 0.5mg/L of vitamin C, 1.8mg/L of vitamin E, 5mg/L of inositol and 1mg/L of calcium pantothenate.
The carbohydrate components are: glucose 1500mg/L, D-ribose 1000mg/L, putrescine 0.05mg/L, ethanolamine 10mg/L, and linoleic acid 0.05mg/L.
The trace elements comprise the following components: copper sulfate pentahydrate 0.05mg/L, zinc sulfate heptahydrate 0.5mg/L, ferrous sulfate heptahydrate 0.5mg/L, cobalt chloride 0.01mg/L, and sodium selenite 0.01mg/L.
The inorganic salt comprises the following components: 1000mg/L sodium bicarbonate, 20mg/L magnesium chloride, 500mg/L sodium chloride and 100mg/L potassium chloride.
Other molecular compound components are: 20mg/L stigmasterol, 20mg/L flavonol, 10mg/L soybean isoflavone, 0.1mg/L insulin, 0.1mg/L cortisol, 0.1mg/L epidermal growth factor, 0.1mg/L EDTA disodium, 10mg/L transferrin, 1mg/L propolis flavone, and 1mg/L epimedium flavone.
Preferably, the serum-free cell culture medium comprises:
the amino acid composition is: 15mg/L of L-histidine, 20mg/L of L-leucine, 25mg/L of L-isoleucine, 10mg/L of L-phenylalanine, 35mg/L of L-lysine, 15mg/L of L-cysteine, 15mg/L of glycine, 30mg/L of L-asparagine, 5mg/L of L-glutamic acid, 5mg/L of L-alanyl-L-glutamine, 10mg/L of L-tryptophan, 50mg/L of L-arginine, 12mg/L of L-tyrosine, 20mg/L of L-aspartic acid, 20mg/L of L-cystine and 6mg/L of L-methionine.
The vitamin components are as follows: vitamin A8 mg/L, vitamin B1.5 mg/L, vitamin B2.5 mg/L, vitamin B3.5 mg/L, vitamin B6.5 mg/L, vitamin B7 1mg/L, vitamin B9 10mg/L, vitamin B15 2.5mg/L, vitamin C2.5 mg/L, vitamin E5.6 mg/L, inositol 20mg/L, calcium pantothenate 5mg/L.
The carbohydrate components are: 2500mg/L glucose, 2000mg/L D-ribose, 2.5mg/L putrescine, 15mg/L ethanolamine and 0.25mg/L linoleic acid.
The trace elements comprise the following components: copper sulfate pentahydrate 0.25mg/L, zinc sulfate heptahydrate 2.5mg/L, ferrous sulfate heptahydrate 5mg/L, cobalt chloride 0.05mg/L, sodium selenite 0.5mg/L.
The inorganic salt comprises the following components: 2000mg/L sodium bicarbonate, 100mg/L magnesium chloride, 1200mg/L sodium chloride and 175mg/L potassium chloride.
Other molecular compound components are: 35mg/L stigmasterol, 35mg/L flavonol, 15mg/L soybean isoflavone, 5mg/L insulin, 10mg/L cortisol, 5mg/L epidermal growth factor, 5mg/L EDTA disodium, 15mg/L transferrin, 5mg/L propolis flavone and 5mg/L epimedium flavone.
Preferably, the serum-free cell culture medium comprises:
the amino acid composition is: 20mg/L of L-histidine, 30mg/L of L-leucine, 35mg/L of L-isoleucine, 15mg/L of L-phenylalanine, 50mg/L of L-lysine, 20mg/L of L-cysteine, 50mg/L of glycine, 50mg/L of L-asparagine, 10mg/L of L-glutamic acid, 10mg/L of L-alanyl-L-glutamine, 20mg/L of L-tryptophan, 100mg/L of L-arginine, 20mg/L of L-tyrosine, 30mg/L of L-aspartic acid, 30mg/L of L-cystine and 10mg/L of L-methionine.
The vitamin components are as follows: vitamin A15 mg/L, vitamin B15 mg/L, vitamin B2 1mg/L, vitamin B3 1mg/L, vitamin B6 5mg/L, vitamin B7 2mg/L, vitamin B9 20mg/L, vitamin B15 mg/L, vitamin C5 mg/L, vitamin E9.4 mg/L, inositol 35mg/L, and calcium pantothenate 10mg/L.
The carbohydrate components are: 3500mg/L glucose, 3000mg/L D-ribose, 5mg/L putrescine, 20mg/L ethanolamine and 0.5mg/L linoleic acid.
The trace elements comprise the following components: copper sulfate pentahydrate 0.5mg/L, zinc sulfate heptahydrate 5mg/L, ferrous sulfate heptahydrate 10mg/L, cobalt chloride 0.1mg/L, sodium selenite 1mg/L.
The inorganic salt comprises the following components: 3000mg/L sodium bicarbonate, 200mg/L magnesium chloride, 2000mg/L sodium chloride and 250mg/L potassium chloride.
Other molecular compound components are: 50mg/L stigmasterol, 50mg/L flavonol, 20mg/L soybean isoflavone, 10mg/L insulin, 20mg/L cortisol, 10mg/L epidermal growth factor, 10mg/L disodium EDTA, 20mg/L transferrin, 10mg/L propolis flavone and 10mg/L epimedium flavone.
Preferably, the use of any of the serum-free cell culture media described above in cell culture comprises: adding any of the above culture media into a culture container filled with cells, and culturing at 37deg.C.
Compared with the prior art, the invention has the following beneficial effects:
compared with the traditional culture medium, the serum-free cell culture medium provided by the invention has the advantages that the serum-free cell culture medium does not contain serum, the components are clear, the cost is low, and the biosafety risk and batch difference caused by using the serum are avoided; and secondly, the culture medium is powered by combining the D-ribose and the glucose, so that more continuous and long-term energy supply can be provided for cells during logarithmic growth and rapid proliferation of the cells, the growth speed of the cells is faster, the metabolism is vigorous, and the activity of the cells is strong. Compared with the traditional culture medium, the cell protein expression amount in the culture medium is higher, and the intracellular toxin is lower, so that greater economic benefit can be realized. In addition, the culture medium provided by the invention can be stored at room temperature, and is convenient to transport and store.
Drawings
FIG. 1 is a graph showing the comparison of viable cell densities of CHO cells cultured by perfusion culture in media 1, 2, and 3 and by batch feed culture in control media 1, 2;
FIG. 2 is a graph showing cell viability comparison of CHO cells perfusion cultured using media 1, 2, 3 and batch feed cultured using control media 1, 2;
description of the embodiments
Examples
This example provides a serum-free cell culture medium comprising an amino acid component, a vitamin component, a carbohydrate component, a trace element component, an inorganic salt component, and other molecular compound components, wherein,
the amino acid composition is: l-histidine 5mg/L, L-leucine 10mg/L, L-isoleucine 15mg/L, L-phenylalanine 5mg/L, L-lysine 20mg/L, L-cysteine 10mg/L, glycine 10mg/L, L-asparagine 10mg/L, L-glutamic acid 1mg/L, L-alanyl-L-glutamine 1mg/L, L-tryptophan 5mg/L, L-arginine 10mg/L, L-tyrosine 5mg/L, L-aspartic acid 10mg/L, L-cystine 10mg/L, L-methionine 3mg/L.
The vitamin components are as follows: 1mg/L of vitamin A, 0.5mg/L of vitamin B, 0.1mg/L of vitamin B, 0.5mg/L of vitamin B, 0.05mg/L of vitamin B, 9 2mg/L of vitamin B, 0.3mg/L of vitamin B, 0.5mg/L of vitamin C, 1.8mg/L of vitamin E, 5mg/L of inositol and 1mg/L of calcium pantothenate.
The carbohydrate components are: glucose 1500mg/L, D-ribose 1000mg/L, putrescine 0.05mg/L, ethanolamine 10mg/L, and linoleic acid 0.05mg/L.
The trace elements comprise the following components: copper sulfate pentahydrate 0.05mg/L, zinc sulfate heptahydrate 0.5mg/L, ferrous sulfate heptahydrate 0.5mg/L, cobalt chloride 0.01mg/L, and sodium selenite 0.01mg/L.
The inorganic salt comprises the following components: 1000mg/L sodium bicarbonate, 20mg/L magnesium chloride, 500mg/L sodium chloride and 100mg/L potassium chloride.
Other molecular compound components are: 20mg/L stigmasterol, 20mg/L flavonol, 10mg/L soybean isoflavone, 0.1mg/L insulin, 0.1mg/L cortisol, 0.1mg/L epidermal growth factor, 0.1mg/L EDTA disodium, 10mg/L transferrin, 1mg/L propolis flavone, and 1mg/L epimedium flavone.
Examples
This example provides a serum-free cell culture medium comprising an amino acid component, a vitamin component, a carbohydrate component, a trace element component, an inorganic salt component, and other molecular compound components, wherein,
the amino acid composition is: 15mg/L of L-histidine, 20mg/L of L-leucine, 25mg/L of L-isoleucine, 10mg/L of L-phenylalanine, 35mg/L of L-lysine, 15mg/L of L-cysteine, 15mg/L of glycine, 30mg/L of L-asparagine, 5mg/L of L-glutamic acid, 5mg/L of L-alanyl-L-glutamine, 10mg/L of L-tryptophan, 50mg/L of L-arginine, 12mg/L of L-tyrosine, 20mg/L of L-aspartic acid, 20mg/L of L-cystine and 6mg/L of L-methionine.
The vitamin components are as follows: vitamin A8 mg/L, vitamin B1.5 mg/L, vitamin B2.5 mg/L, vitamin B3.5 mg/L, vitamin B6.5 mg/L, vitamin B7 1mg/L, vitamin B9 10mg/L, vitamin B15 2.5mg/L, vitamin C2.5 mg/L, vitamin E5.6 mg/L, inositol 20mg/L, calcium pantothenate 5mg/L.
The carbohydrate components are: 2500mg/L glucose, 2000mg/L D-ribose, 2.5mg/L putrescine, 15mg/L ethanolamine and 0.25mg/L linoleic acid.
The trace elements comprise the following components: copper sulfate pentahydrate 0.25mg/L, zinc sulfate heptahydrate 2.5mg/L, ferrous sulfate heptahydrate 5mg/L, cobalt chloride 0.05mg/L, sodium selenite 0.5mg/L.
The inorganic salt comprises the following components: 2000mg/L sodium bicarbonate, 100mg/L magnesium chloride, 1200mg/L sodium chloride and 175mg/L potassium chloride.
Other molecular compound components are: 35mg/L stigmasterol, 35mg/L flavonol, 15mg/L soybean isoflavone, 5mg/L insulin, 10mg/L cortisol, 5mg/L epidermal growth factor, 5mg/L EDTA disodium, 15mg/L transferrin, 5mg/L propolis flavone and 5mg/L epimedium flavone.
Examples
This example provides a serum-free cell culture medium comprising an amino acid component, a vitamin component, a carbohydrate component, a trace element component, an inorganic salt component, and other molecular compound components, wherein,
the amino acid composition is: 20mg/L of L-histidine, 30mg/L of L-leucine, 35mg/L of L-isoleucine, 15mg/L of L-phenylalanine, 50mg/L of L-lysine, 20mg/L of L-cysteine, 50mg/L of glycine, 50mg/L of L-asparagine, 10mg/L of L-glutamic acid, 10mg/L of L-alanyl-L-glutamine, 20mg/L of L-tryptophan, 100mg/L of L-arginine, 20mg/L of L-tyrosine, 30mg/L of L-aspartic acid, 30mg/L of L-cystine and 10mg/L of L-methionine.
The vitamin components are as follows: vitamin A15 mg/L, vitamin B15 mg/L, vitamin B2 1mg/L, vitamin B3 1mg/L, vitamin B6 5mg/L, vitamin B7 2mg/L, vitamin B9 20mg/L, vitamin B15 mg/L, vitamin C5 mg/L, vitamin E9.4 mg/L, inositol 35mg/L, and calcium pantothenate 10mg/L.
The carbohydrate components are: 3500mg/L glucose, 3000mg/L D-ribose, 5mg/L putrescine, 20mg/L ethanolamine and 0.5mg/L linoleic acid.
The trace elements comprise the following components: copper sulfate pentahydrate 0.5mg/L, zinc sulfate heptahydrate 5mg/L, ferrous sulfate heptahydrate 10mg/L, cobalt chloride 0.1mg/L, sodium selenite 1mg/L.
The inorganic salt comprises the following components: 3000mg/L sodium bicarbonate, 200mg/L magnesium chloride, 2000mg/L sodium chloride and 250mg/L potassium chloride.
Other molecular compound components are: 50mg/L stigmasterol, 50mg/L flavonol, 20mg/L soybean isoflavone, 10mg/L insulin, 20mg/L cortisol, 10mg/L epidermal growth factor, 10mg/L disodium EDTA, 20mg/L transferrin, 10mg/L propolis flavone and 10mg/L epimedium flavone.
Example 4 preparation of culture Medium for experiments
Adding 1L of each component of the culture medium into 800ml of ultrapure water, stirring at room temperature for 30min until all the components are dissolved, regulating the pH value to 7.0-7.3 by using a freshly prepared 1M hydrochloric acid or sodium hydroxide solution, then performing positive pressure filtration sterilization by using a 0.22 mu M sterile filter membrane, and preserving at room temperature for later use.
The preparation of the culture medium for the specific experiment comprises the following steps:
the medium of example 1 was stirred at room temperature for 30min with an amount of 1L of each component added to 800ml of ultrapure water until all components were dissolved, the pH was adjusted to 7.1 with freshly prepared 1M hydrochloric acid or sodium hydroxide solution, and then sterilized by positive pressure filtration through a 0.22 μm sterile filter, and stored at room temperature for later use, labeled medium 1.
The medium of example 2, labeled Medium 2, was prepared in the same manner as the preparation method.
The medium of example 3, labeled Medium 3, was prepared in the same manner as the preparation method.
Commercial medium DMEM (purchased from Gibco) was supplemented with 10% fetal bovine serum as control medium 1.
Commercial Medium SFM (from Gibco) was used as control Medium 2.
Examples
Taking 5T 75 flash cell culture flasks, and respectively adding culture mediums 1, 2 and 3 and control culture mediums 1 and 2; inoculating resuscitated Vero cell strain into the above 5 culture flasks at a density of 1×10 4 Individual/cm 2 ,37℃,5%CO 2 After 4 days of culture, the cells were digested, and 1ml of pancreatin stop solution was used to terminate the digestion and collect the cells. Cell morphology was observed, the average cell density and viability for each medium was counted using a Cedex AS-20 cell density and viability autoanalyzer, and the endotoxin content was measured using an endotoxin detector.
The results show that: the cell density and cell activity of the culture mediums 1, 2 and 3 are obviously superior to those of the control culture mediums 1 and 2, the cell expansion capacity can reach 3 times that of the control culture mediums 1 and 2, the cell growth state is better, and the activity is higher; the endotoxin content of the cells in the culture media 1, 2 and 3 was reduced by 3/5~4/5 compared to the control culture media 1 and 2. See table 1.
TABLE 1
Culture medium | Cell density (. Times.10) 6 Personal/ml) | Cell viability (%) | Endotoxin content (EU/ml) |
Culture medium 1 | 3.87 | 99 | 1.17 |
Culture medium 2 | 3.94 | 99 | 1.05 |
Culture medium 3 | 3.85 | 99 | 1.21 |
Control Medium 1 | 1.23 | 87 | 5.24 |
Control Medium 2 | 1.04 | 85 | 4.96 |
Examples
In this example, CHO cells expressing t-PA were used as subjects, and the culture medium provided by the present invention and the control medium were evaluated for their effects by detecting the viable cell density, cell viability and the content of expressed t-PA protein, in the following manner:
6.1 CHO cell lines expressing t-PA were grown at 1X 10 6 The density of each/ml was inoculated into a flask containing 30ml of medium 1, 2, 3, respectively, and the flask was placed in a flask containing 5% CO 2 The culture was carried out at 37℃at 120rpm, and then 30% of the culture volume per day, i.e., 9ml of the cell culture solution was obtained, and 300g was centrifuged for 5 minutes, and the supernatant was discarded, and the cells were resuspended in 9ml of each of the new media 1, 2 and 3, and then each of them was added to the original flask and continued to be cultured for 32 days.
6.2 CHO cell lines expressing t-PA were grown at 1X 10 6 The density of each/ml was inoculated into a flask containing 30ml of control medium 1, 2, respectively, and the flask was placed in a flask containing 5% CO 2 In the shaker at 37℃at 120rpm, 3, 5, 7, 9, 11, 13 and 15 days of culture, 5% of the initial culture volume of Celsource CHO cell feed medium was added, respectively.
6.3 Results
6.3.1 FIG. 1 shows the comparison of viable cell densities of CHO cells grown in perfusion culture with media 1, 2, 3 and in fed batch culture with control media 1, 2, showing that media 1, 2, 3 are capable of high density growth (32 days) for longer periods of time than control media fed batch culture, with media 2 being optimally effective.
6.3.2 FIG. 2 shows the cell viability of CHO cells in perfusion culture using medium 1, 2, 3 compared to control medium 1, 2 in fed batch culture, demonstrating that medium 1, 2, 3 is capable of maintaining high viability growth for longer periods of time, with a cell viability of greater than 90% on day 32, compared to control medium fed batch culture, where the effect of medium 2 is optimal.
6.3.3 Table 2 shows that the perfusion culture of CHO cells using culture media 1, 2 and 3 and the batch feed culture of control culture media 1 and 2 show that the culture media 1, 2 and 3 have higher (3 times) expression level of t-PA protein and more stable yield compared with the batch feed culture of control culture media, wherein the effect of culture media 2 is optimal.
TABLE 2
The technical scheme of the invention is further described through the specific embodiments. It should be apparent to those skilled in the art that the examples are merely provided to aid in understanding the present invention and should not be construed as limiting the invention in any way.
Claims (5)
1. A serum-free cell culture medium comprises an amino acid component, a vitamin component, a carbohydrate component, a trace element component, an inorganic salt component and other molecular compound components, and is characterized in that,
the amino acid component comprises the following components:
the vitamin component comprises the following components:
the carbohydrate component comprises the following ingredients:
the trace element component comprises the following components:
the inorganic salt component comprises the following components:
the other molecular compound components include the following:
2. serum-free cell culture medium according to claim 1, characterized in that the medium is formulated as follows:
the amino acid composition is: l-histidine 5mg/L, L-leucine 10mg/L, L-isoleucine 15mg/L, L-phenylalanine 5mg/L, L-lysine 20mg/L, L-cysteine 10mg/L, glycine 10mg/L, L-asparagine 10mg/L, L-glutamic acid 1mg/L, L-alanyl-L-glutamine 1mg/L, L-tryptophan 5mg/L, L-arginine 10mg/L, L-tyrosine 5mg/L, L-aspartic acid 10mg/L, L-cystine 10mg/L, L-methionine 3mg/L. The vitamin components are as follows: 1mg/L of vitamin A, 0.5mg/L of vitamin B, 0.1mg/L of vitamin B, 0.5mg/L of vitamin B, 0.05mg/L of vitamin B, 9 2mg/L of vitamin B, 0.3mg/L of vitamin B, 0.5mg/L of vitamin C, 1.8mg/L of vitamin E, 5mg/L of inositol and 1mg/L of calcium pantothenate. The carbohydrate components are: glucose 1500mg/L, D-ribose 1000mg/L, putrescine 0.05mg/L, ethanolamine 10mg/L, and linoleic acid 0.05mg/L. The trace elements comprise the following components: copper sulfate pentahydrate 0.05mg/L, zinc sulfate heptahydrate 0.5mg/L, ferrous sulfate heptahydrate 0.5mg/L, cobalt chloride 0.01mg/L, and sodium selenite 0.01mg/L. The inorganic salt comprises the following components: 1000mg/L sodium bicarbonate, 20mg/L magnesium chloride, 500mg/L sodium chloride and 100mg/L potassium chloride. Other molecular compound components are: 20mg/L stigmasterol, 20mg/L flavonol, 10mg/L soybean isoflavone, 0.1mg/L insulin, 0.1mg/L cortisol, 0.1mg/L epidermal growth factor, 0.1mg/L EDTA disodium, 10mg/L transferrin, 1mg/L propolis flavone, and 1mg/L epimedium flavone. Other molecular compound components are: 20mg/L stigmasterol, 20mg/L flavonol, 10mg/L soybean isoflavone, 0.1mg/L insulin, 0.1mg/L cortisol, 0.1mg/L epidermal growth factor, 0.1mg/L EDTA disodium, 10mg/L transferrin, 1mg/L propolis flavone, and 1mg/L epimedium flavone.
3. Serum-free cell culture medium according to claim 1, characterized in that the medium is formulated as follows:
the amino acid composition is: 15mg/L of L-histidine, 20mg/L of L-leucine, 25mg/L of L-isoleucine, 10mg/L of L-phenylalanine, 35mg/L of L-lysine, 15mg/L of L-cysteine, 15mg/L of glycine, 30mg/L of L-asparagine, 5mg/L of L-glutamic acid, 5mg/L of L-alanyl-L-glutamine, 10mg/L of L-tryptophan, 50mg/L of L-arginine, 12mg/L of L-tyrosine, 20mg/L of L-aspartic acid, 20mg/L of L-cystine and 6mg/L of L-methionine. The vitamin components are as follows: vitamin A8 mg/L, vitamin B1.5 mg/L, vitamin B2.5 mg/L, vitamin B3.5 mg/L, vitamin B6.5 mg/L, vitamin B7 1mg/L, vitamin B9 10mg/L, vitamin B15 2.5mg/L, vitamin C2.5 mg/L, vitamin E5.6 mg/L, inositol 20mg/L, calcium pantothenate 5mg/L. The carbohydrate components are: 2500mg/L glucose, 2000mg/L D-ribose, 2.5mg/L putrescine, 15mg/L ethanolamine and 0.25mg/L linoleic acid. The trace elements comprise the following components: copper sulfate pentahydrate 0.25mg/L, zinc sulfate heptahydrate 2.5mg/L, ferrous sulfate heptahydrate 5mg/L, cobalt chloride 0.05mg/L, sodium selenite 0.5mg/L. The inorganic salt comprises the following components: 2000mg/L sodium bicarbonate, 100mg/L magnesium chloride, 1200mg/L sodium chloride and 175mg/L potassium chloride. Other molecular compound components are: 35mg/L stigmasterol, 35mg/L flavonol, 15mg/L soybean isoflavone, 5mg/L insulin, 10mg/L cortisol, 5mg/L epidermal growth factor, 5mg/L EDTA disodium, 15mg/L transferrin, 5mg/L propolis flavone and 5mg/L epimedium flavone.
4. Serum-free cell culture medium according to claim 1, characterized in that the medium is formulated as follows:
the amino acid composition is: 20mg/L of L-histidine, 30mg/L of L-leucine, 35mg/L of L-isoleucine, 15mg/L of L-phenylalanine, 50mg/L of L-lysine, 20mg/L of L-cysteine, 50mg/L of glycine, 50mg/L of L-asparagine, 10mg/L of L-glutamic acid, 10mg/L of L-alanyl-L-glutamine, 20mg/L of L-tryptophan, 100mg/L of L-arginine, 20mg/L of L-tyrosine, 30mg/L of L-aspartic acid, 30mg/L of L-cystine and 10mg/L of L-methionine. The vitamin components are as follows: vitamin A15 mg/L, vitamin B15 mg/L, vitamin B2 1mg/L, vitamin B3 1mg/L, vitamin B6 5mg/L, vitamin B7 2mg/L, vitamin B9 20mg/L, vitamin B15 mg/L, vitamin C5 mg/L, vitamin E9.4 mg/L, inositol 35mg/L, and calcium pantothenate 10mg/L. The carbohydrate components are: 3500mg/L glucose, 3000mg/L D-ribose, 5mg/L putrescine, 20mg/L ethanolamine and 0.5mg/L linoleic acid. The trace elements comprise the following components: copper sulfate pentahydrate 0.5mg/L, zinc sulfate heptahydrate 5mg/L, ferrous sulfate heptahydrate 10mg/L, cobalt chloride 0.1mg/L, sodium selenite 1mg/L. The inorganic salt comprises the following components: 3000mg/L sodium bicarbonate, 200mg/L magnesium chloride, 2000mg/L sodium chloride and 250mg/L potassium chloride. Other molecular compound components are: 50mg/L stigmasterol, 50mg/L flavonol, 20mg/L soybean isoflavone, 10mg/L insulin, 20mg/L cortisol, 10mg/L epidermal growth factor, 10mg/L disodium EDTA, 20mg/L transferrin, 10mg/L propolis flavone and 10mg/L epimedium flavone.
5. A method of cell culture comprising: the culture medium according to any one of claims 1 to 4 is added into a culture container filled with cells, and the cells are cultured at 37 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310424864.5A CN116731951A (en) | 2023-04-20 | 2023-04-20 | Serum-free cell culture medium and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310424864.5A CN116731951A (en) | 2023-04-20 | 2023-04-20 | Serum-free cell culture medium and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116731951A true CN116731951A (en) | 2023-09-12 |
Family
ID=87906806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310424864.5A Pending CN116731951A (en) | 2023-04-20 | 2023-04-20 | Serum-free cell culture medium and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116731951A (en) |
-
2023
- 2023-04-20 CN CN202310424864.5A patent/CN116731951A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105018416B (en) | A kind of non-animal derived culture medium of serum-free and its preparation method of the culture BHK-21 cell that suspends | |
CN102827804B (en) | Culture medium and method suitable for the amplification culture of Vero cell microcarrier suspension | |
JP4532493B2 (en) | Cell culture media | |
EP2752484B1 (en) | Method for preparing a basic culture medium for mesenchymal stem cells, basic culture medium for mesenchymal stem cells, and cell therapeutic agent cultured and differentiated using same | |
CN109337861B (en) | CHO cell serum-free medium supporting high expression of product | |
EP1097194A2 (en) | Serum-free medium for culturing animal cells | |
CN106834229B (en) | Serum-free medium for in vitro expansion of human immune killer cells | |
CN101760442A (en) | Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture | |
EP3417053B1 (en) | Chemically defined medium for the culture of cancer stem cell (csc) containing cell populations | |
Kaighn et al. | Growth control of prostatic carcinoma cells in serum-free media: interrelationship of hormone response, cell density, and nutrient media. | |
CN111440764A (en) | Serum-free culture medium of mesenchymal stem cells and clinical-grade large-scale culture method of mesenchymal stem cells | |
CN111518768B (en) | Low-serum culture medium suitable for LMH cell wall-attached culture and preparation method thereof | |
CN116790477A (en) | Serum-free culture medium supporting CHO cell high-density culture and preparation method and application thereof | |
CN116731951A (en) | Serum-free cell culture medium and application thereof | |
CN1269956C (en) | Non serum substratum for in vitro culture and amplification of cutaneous keratin cell | |
EP0550638A4 (en) | Medium for culture of mammalian cells | |
CN105087460A (en) | ST cell culture medium | |
JPS5974982A (en) | Cell growth medium replenishing agent and method of growing cell in vitro | |
CN115843784B (en) | CAR-NK cell preservation solution, preparation method and preservation method thereof | |
CN106561632A (en) | Freezing preservation solution used for adipose-derived stem cells as well as preparation method for freezing preservation solution and culture medium | |
CN102140439A (en) | In-vitro culture method of adipocytes of large yellow croaker | |
CN116731956A (en) | Culture medium of mammalian cells, culture method thereof and preparation method of antibody | |
CN110117573A (en) | A kind of serum-free cell culture medium and its application | |
CN107119017B (en) | Serum-free culture medium for osteosarcoma cells and preparation method thereof | |
CN113862217A (en) | Methods of culturing mammalian cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |